La Trobe

MYB orchestrates T cell exhaustion and response to checkpoint inhibition

Download (55.49 MB)
journal contribution
posted on 2023-07-07, 04:05 authored by C Tsui, L Kretschmer, S Rapelius, SS Gabriel, David Chisanga, K Knöpper, DT Utzschneider, S Nüssing, Yang Liao, T Mason, SV Torres, SA Wilcox, K Kanev, S Jarosch, J Leube, SL Nutt, D Zehn, IA Parish, W Kastenmüller, Wei ShiWei Shi, VR Buchholz, A Kallies

CD8+ T cells that respond to chronic viral infections or cancer are characterized by the expression of inhibitory receptors such as programmed cell death protein 1 (PD-1) and by the impaired production of cytokines. This state of restrained functionality—which is referred to as T cell exhaustion1,2—is maintained by precursors of exhausted T (TPEX) cells that express the transcription factor T cell factor 1 (TCF1), self-renew and give rise to TCF1− exhausted effector T cells 3–6. Here we show that the long-term proliferative potential, multipotency and repopulation capacity of exhausted T cells during chronic infection are selectively preserved in a small population of transcriptionally distinct CD62L+ TPEX cells. The transcription factor MYB is not only essential for the development of CD62L+ TPEX cells and maintenance of the antiviral CD8+ T cell response, but also induces functional exhaustion and thereby prevents lethal immunopathology. Furthermore, the proliferative burst in response to PD-1 checkpoint inhibition originates exclusively from CD62L+ TPEX cells and depends on MYB. Our findings identify CD62L+ TPEX cells as a stem-like population that is central to the maintenance of long-term antiviral immunity and responsiveness to immunotherapy. Moreover, they show that MYB is a transcriptional orchestrator of two fundamental aspects of exhausted T cell responses: the downregulation of effector function and the long-term preservation of self-renewal capacity.

Funding

This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Research Fellowship (to A.K.) and Ideas Grants (APP2004333 to A.K. and C.T.; APP2001719 to I.A.P.); the European Research Council (starting grant 949719 SCIMAP to V.R.B.); the Else Kroner-Fresenius-Stiftung (EKFS 2019_A91 to V.R.B.); the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; SFB-TRR 338/1 2021-452881907, SFB 1054-210592381 to V.R.B.); and the Deutsche Krebshilfe (DKH 70113918 to V.R.B).

History

Publication Date

2022-09-08

Journal

Nature

Volume

609

Issue

7926

Pagination

32p. (p. 354-386)

Publisher

Springer Nature

ISSN

0028-0836

Rights Statement

© 2022 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC